Wall Street brokerages predict that Steris PLC (NYSE:STE) will report earnings per share (EPS) of $1.22 for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Steris’ earnings, with estimates ranging from $1.22 to $1.23. Steris posted earnings per share of $1.11 during the same quarter last year, which would suggest a positive year-over-year growth rate of 9.9%. The company is scheduled to issue its next earnings results on Tuesday, May 8th.
According to Zacks, analysts expect that Steris will report full year earnings of $4.12 per share for the current year, with EPS estimates ranging from $4.08 to $4.14. For the next year, analysts expect that the company will post earnings of $4.68 per share, with EPS estimates ranging from $4.55 to $4.77. Zacks’ EPS calculations are a mean average based on a survey of research analysts that follow Steris.
Steris (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.05. The firm had revenue of $661.90 million for the quarter, compared to analyst estimates of $663.17 million. Steris had a net margin of 9.42% and a return on equity of 11.57%. Steris’s quarterly revenue was up 2.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.98 earnings per share.
In related news, VP Sudhir K. Pahwa sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $92.09, for a total transaction of $184,180.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Richard Martin Steeves sold 58,953 shares of the company’s stock in a transaction that occurred on Monday, March 5th. The stock was sold at an average price of $91.00, for a total transaction of $5,364,723.00. Following the sale, the director now directly owns 9,362 shares in the company, valued at $851,942. The disclosure for this sale can be found here. Insiders sold a total of 68,415 shares of company stock worth $6,223,536 over the last three months. Insiders own 2.55% of the company’s stock.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Crossmark Global Holdings Inc. acquired a new position in Steris during the 3rd quarter worth approximately $812,000. Canada Pension Plan Investment Board grew its holdings in Steris by 13.2% during the 3rd quarter. Canada Pension Plan Investment Board now owns 54,100 shares of the medical equipment provider’s stock worth $4,782,000 after acquiring an additional 6,300 shares in the last quarter. State Board of Administration of Florida Retirement System grew its holdings in Steris by 83.0% during the 3rd quarter. State Board of Administration of Florida Retirement System now owns 29,010 shares of the medical equipment provider’s stock worth $2,564,000 after acquiring an additional 13,160 shares in the last quarter. State of Tennessee Treasury Department grew its holdings in Steris by 20.0% during the 3rd quarter. State of Tennessee Treasury Department now owns 60,000 shares of the medical equipment provider’s stock worth $5,304,000 after acquiring an additional 10,000 shares in the last quarter. Finally, Prudential Financial Inc. grew its holdings in Steris by 14.4% during the 3rd quarter. Prudential Financial Inc. now owns 192,686 shares of the medical equipment provider’s stock worth $17,034,000 after acquiring an additional 24,220 shares in the last quarter. 88.41% of the stock is currently owned by hedge funds and other institutional investors.
Steris (STE) traded up $1.75 on Friday, reaching $95.20. 412,619 shares of the company were exchanged, compared to its average volume of 376,870. The firm has a market capitalization of $8,080.00, a price-to-earnings ratio of 33.52 and a beta of 1.17. Steris has a 52-week low of $67.55 and a 52-week high of $95.41. The company has a quick ratio of 2.22, a current ratio of 2.82 and a debt-to-equity ratio of 0.46.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 28th. Stockholders of record on Wednesday, February 28th will be paid a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.30%. This is an increase from Steris’s previous quarterly dividend of $0.21. The ex-dividend date is Tuesday, February 27th. Steris’s payout ratio is 43.66%.
COPYRIGHT VIOLATION WARNING: “Analysts Expect Steris PLC (STE) to Announce $1.22 Earnings Per Share” was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/3256019/analysts-expect-steris-plc-ste-to-announce-1-22-earnings-per-share.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.